← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Xenotech, Llc
Lenexa, KS
$1,178,553
Total funding
2
Grants
Funding over time
peak $193.4K · FY2009–20$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,178,553 · 2
By mechanism
N01$1,178,553 · 2
Investigators at Xenotech, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IN VITRO METABOLISM$193,420
N01 · FY2011 · DA
IN VITRO METABOLISM$193,420
N01 · FY2010 · DA
IN VITRO METABOLISM$193,419
N01 · FY2009 · DA
IGF::OT::IGF PURPOSE: TO FULLY FUND THE PERFORMANCE UNDER TASK ORDER 2 PERIOD OF PERFORMANCE: 09/03/2015 - 09/02/2016$179,536
N01 · FY2016 · DA
IGF::OT::IGF : IN VITRO METABOLISM & METABOLITE QUANTIFICATION. PERIOD OF PERFORMANCE: 07/06/2015-07/05/2020. N01DA-15-8919.$74,732
N01 · FY2019 · DA
IGF::OT::IGF PURPOSE: TO FULLY FUND THE PERFORMANCE UNDER TASK ORDER 2 PERIOD OF PERFORMANCE: 09/03/2015 - 09/02/2016$74,732
N01 · FY2017 · DA
IN VITRO METABOLISM$70,653
N01 · FY2013 · DA
IN VITRO METABOLISM$70,653
N01 · FY2012 · DA
IGF::OT::IGF : IN VITRO METABOLISM & METABOLITE QUANTIFICATION. PERIOD OF PERFORMANCE: 07/06/2015-07/05/2020. N01DA-15-8919.$64,060
N01 · FY2018 · DA
IGF::OT::IGF PURPOSE: TO FULLY FUND THE PERFORMANCE UNDER TASK ORDER 2 PERIOD OF PERFORMANCE: 09/03/2015 - 09/02/2016$39,955
N01 · FY2015 · DA
TO FULLY FUND PERFORMANCE UNDER TASK ORDER NO. 9. PERIOD OF PERFORMANCE: 07/02/2020 - 09/02/2020. N01DA-15-8919.$23,973
N01 · FY2020 · DA